The 3rd Bode China (International) In-Vitro Diagnostics Industry Forum, which is organized by China Association of In-vitro Diagnostics and Broad (Shanghai) Exhibition Business Co., Ltd, was successfully held at Xian Qujiang International Conference Center on March 6, 2016.

This time our topics are: Chinese IVD’s Innovation, Transition and Internet Plus in the New Normal. Chairman of the forum is Mr. Lian Xinting from Nanchang Biotech A&C Biotechnical Industry Incorporated Co. Two hosts are Mr. Miao Yongjun from Autobio Diagnostics Co., Ltd. and Mr. Sun Yifeng from Zhuhai Encode Medical Engineering Co., Ltd.

Guests attending the forum are:

Chairman:

Mr. Song Haibo,  chief editor of the editorial committee of Chinese IVD industry yearbook and www.caivd.org

Vice-Chairman & Secretary General:

Mr. Zhu Yaoyi, Chairman of China Association for Medical Devices Industry’s IVD Chapter, President of  Shanghai Fosun Long March Medical Science Co., Ltd. 

Vice Chairman: 

Wang Hualiang, Wang Jun, Wang Mu, Wang Jingdong, Ye Chen, Shi Hong, Zhu Shaorong, Sun Yifeng, Li Wenmei, Yang Zengli, Zou Zuojun, Song Yong, Zhang Guohua, Chen Yue, Zheng Zehui, Lian Xinting, Shi Huiyong, Yao Jianer, Dong Tongyi, Dong Huijun. 

Vice Secretary General: 

Qu Chong, Jiang Tao, Luo Yimin, Yao Gang, Luan Aiqun, Wang Bangkan, Wang Manchong, Jiang Zhi, Gan Yiwu, Liu Jian, Yu Zhanjiang, Zhang Feng, Zhao Xiaohui, Qin Xiaorui, Cao Zhuang, Chen Jiannong, Tong Jingsong.

Over 700 people attend the forum, including specialists, entrepreneurs and IVD-related staff from all over China.

The forum starts at 8:30 am and Mr. Lian Xinting gives an opening speech. 

Mr. Sun Yifeng is of host of the forum in the morning.

‘Internet Plus’has become a national strategy, so how we face ‘Internet Plus IVD’ will be an important problem in front of us. In the forum, we invited Mr. Huang Yongquan，vice president and marketing director of Nanchang Biotech to share his Internet Plus’ Influence on the development of IVD Industry, which is both innovative and brilliant.

Prof. Zhang Heqiu addresses on The New Immunoassay Method and Application for Mycobacterium Tuberculosis Infection.

Prof. Su Xunzhi gives his lecture on The Key points of Pre-IPO for IVD Companies, which I think will provide important guides for enterprises seeking for public offerings.

During the forum, Chairman Song Haibo introduced Mr. Zhu Yunfeng from Medical Reform Office of the State Council and his investigation on the situations of medical and health industry in Henan and Shanxi.

Mr. Zhu Yunfeng was informed of the host of Bode forum and specially come to the forum for observation. 

Also we invite Prof. Yue Wei to make a Summary of Chinese IVD Regulation, which will play a guiding role in the governmental call of encouraging people to start their own business and to make innovations.

Glycosylated hemoglobin expert Andrew Buck from Britain will share his Approaches and Progresses to HbA1c Testing in the Clinical Laboratory with us.

From 1:30 pm, Mr. Miao Yongjun has become the host.

we are very honored to have invited Prof. Deng Yulin to share his opinion on Research of Translational Medicine Fuses Genetic Engineering Technology.

IVD companies turn to capitalization will be a trend in the next few years and it’s also an essential way for us to catch up with foreign Giants. This time we have invited Prof. Li Wenmei, president of the recently listed company Guangzhou Wonfo Biotech to share his How Does Capital Market Promote the Development of IVD Industry.

Lawyer Jiang Jin shared his knowledge on IVD legal risk prevention and typical case analysis.

We especially invited Prof. Cong Yulong, one of the respected leaders in China IVD industry, to make a speech on The Opportunities and Challenges of IVD Industry Under the New Normal.

Dr. Fu Qihua also talks about Molecular Diagnosis of Birth Defects. These are all leading subjects in IVD industry and I’m sure you can benefit a great deal from it.

In addition, we have vice chairman of CAIVD Mr. Zhu Yaoyi to release the valuable 2015 China IVD Industry Annual Report.

Mr. Lian Xinting is the host of the last stage, which is a interactive interview focused on common concerned topics such as innovation, governmental regulations, investment, translational medicine, industry situation, internet plus and so on.

Guests being interviewed include Song Haibo, Lian Xinting, Miao Yongjun, Sun Yifeng, Huang Yongquan, Zhang Heqiu, Su Zhixun, Yue Wei, Andrew John Buck, Deng Yuling, Li Wenmei, Jiang Jin, Cong Yulong, Fu Qihua, Zhu Yaoyi, Jiao Lin.

Representatives attending the forum raised a variety of questions and discussed on common concerned topics together. The forum went with a competitive and enthusiastic atmosphere and ended in prolonged applause.